Are birthweight and postnatal weight gain in childhood associated with blood pressure in early adolescence? Results from a Ugandan birth cohort

Background In Africa, where low birthweight (LBW), malnutrition and high blood pressure (BP) are prevalent, the relationships between birthweight (BW), weight gain and BP later in life remain uncertain. We examined the effects of early life growth on BP among Ugandan adolescents. Methods Data were collected prenatally from women and their offspring were followed from birth, with BP measured following standard protocols in early adolescence. Weight-for-age Z-scores (WAZ) were computed using World Health Organization references. Linear regression was used to relate BW, and changes in WAZ between birth and 5 years, to adolescents’ BP, adjusting for confounders. Results Among 2345 live offspring, BP was measured in 1119 (47.7%) adolescents, with mean systolic BP 105.9 mmHg and mean diastolic BP 65.2 mmHg. There was little evidence of association between BW and systolic [regression coefficient β = 0.14, 95% confidence interval (CI) (-1.00, 1.27)] or diastolic [β = 0.43, 95% CI (-0.57, 1.43)] BP. Accelerated weight gain between birth and 5 years was associated with increased BP: systolic β = 1.17, 95% CI (0.69, 1.66) and diastolic β = 1.03, 95% CI (0.59, 1.47). Between birth and 6 months of age, effects of accelerated weight gain on adolescent BP were strongest among the LBW (both premature and small-for-gestational-age) children [BW < 2.5 kg: β = 2.64, 95% CI (0.91, 4.37), BW≥2.5 kg: β = 0.58, 95% CI (0.01, 1.14), interaction P-value =0.024]. Conclusions Findings from this large tropical birth cohort in Uganda suggest that postnatal weight gain rather than BW is important in the developmental programming of BP, with fast-growing LBW children at particular risk. Efforts to control BP should adopt a life course approach.

Adolescents from the EMaBS, a randomized, double-blind, placebo-controlled trial designed to investigate the effects of worms and their treatment in pregnancy and childhood on vaccine responses and infections in the children,18 were enrolled into the BP study. As previously described,18 from 2003 to 2005, pregnant women attending antenatal care at Entebbe Hospital and residing in the study area were enrolled and randomized to receive single-dose praziquantel or matching placebo and single-dose albendazole or matching placebo in a 2 x 2 factorial design. Those with evidence of helminth-induced pathology or history of adverse reaction to anthelminthics or abnormal pregnancy, or who had enrolled for an earlier pregnancy, were excluded.19 At 15 months, the resulting offspring were randomized to receive quarterly albendazole or matching placebo up to age 5 years.18 Demographic, socioeconomic and health information was collected prenatally (from pregnant women) and from birth onwards from the live-born offspring. Birthweight was measured immediately after birth using scales (Fazzini SRL, Vimodrone, Italy) for those delivered in Entebbe hospital. For offspring delivered elsewhere, BW was recorded as written on the child health card. Weight was measured at 6 weeks and 6 months of age, using CMS weighing equipment (model MP25: Chasmors Ltd, London, UK) and then annually (close to the child’s birthday) using weighing scales (Seca, Hamburg, Germany). Height was measured as recumbent length at age 6 weeks using an adjustable child-length measuring board (Seca, Hamburg, Germany), then annually (from age 1 year) using stadiometers (Seca 213, Hamburg, Germany). BMI was weight in kilograms (kg) divided by height in metres (m) squared. Children continued under follow-up after the trial intervention ended in 2011. Between 2 May 2014 and 1 June 2016, those attending their visit at ages 10 or 11 years and not presenting with an illness were enrolled in the BP study; 11-year-olds were excluded if they were previously enrolled as 10-year-olds. Trained nurses measured BP thrice 5 minutes apart, using an appropriate-sized cuff20 on the right arm supported at the heart level, with the participant seated upright all the way to the back of the chair, legs uncrossed and feet flat on the floor. Automated Omron (M6, HEM-700) machines, validated every 6 months by the Uganda National Bureau of Standards, were used. Means of the three systolic and diastolic BP were calculated. Blood pressure percentiles were obtained using Center for Disease Control height percentile charts and National Health and Nutrition Examination Survey Working Group on Children and Adolescents BP tables.20,21 Adolescents with mean BP (systolic and/or diastolic) measurements ≥95th percentile for gender, age and height on day 1 had BP measured for up to two extra days. Those sustaining a high BP on day 3 were referred for specialist attention. Non-pharmacological management was recommended to adolescents with BP (systolic and/or diastolic) ≥90th percentile for age, gender and height. The study was approved by ethics committees of the Uganda Virus Research Institute, the London School of Hygiene and Tropical Medicine and the Uganda National Council for Science and Technology. Written informed consent and assent were obtained. Data were double-entered in Microsoft Access and analysed using Stata 14 (College Station, TX, USA). Characteristics of cohort members enrolled and not enrolled in the BP study were compared using chi-square tests. The study outcomes were systolic and diastolic BP. The mean of the second and third day-1 BP measurements was used for analysis, as these were on average different from and lower than the first day-1 measurements (Supplementary Figure 1, available as Supplementary data at IJE online). Key exposures were BW and postnatal weight gain. Postnatal weight gain was change in weight-for-age Z-score (WAZ) between birth and age 5 years, with shorter growth periods (birth to 6 months, 6 to 12 months, 12 to 24 months and 24 to 60 months) also examined. The 2006 World Health Organization standard references22,23 were used to calculate WAZ, weight-for-height Z-score (WHZ) and BMI-for-age Z-score (BMIZ). Potential confounders were maternal characteristics including sociodemographic (age, education, area of residence, socioeconomic status), BMI, pregnancy anthelminthic trial interventions, illness and infections (hypertension, HIV, malaria, worms), and child’s characteristics including sex, feeding status, BMI, age, childhood anthelminthic trial intervention, illness and infections (malaria, worms). Pearson correlation coefficients between BMI at age 10–11 years and anthropometric variables (WAZ, WHZ and BMIZ) at birth, 6 weeks, 6 months and annually from 1 to 5 years were calculated. Linear regression (fitted separately for systolic and diastolic BP) was used to assess the association between each key exposure and adolescent BP. Adolescents’ age and sex were included a priori in all models. Regression models were adjusted for each potential confounder in turn, with those causing an important change in the effect of the exposure of interest on BP retained in the final model. Final models with and without current weight were fitted. For BW, we assessed whether a linear or non-linear (categorical or quadratic) relationship provided a better fit to the data. Likelihood ratio test (LRT) was used to examine for effect modification by gender, original trial interventions and birth season. Since the timing of wet seasons in this setting is subject to variability, birth months were categorized as either dry or wet depending on whether the total monthly rainfall was below or above the median rainfall for all birth months. For weight gain, as well as for those confounders identified in the BW exposure analysis, the effect of each growth period was adjusted for earlier postnatal weight gain period(s) and feeding status at 6 weeks. Effect modification by gender or BW (<2.5 kg versus ≥2.5 kg) was assessed using LRT. Sensitivity analysis assessing the impact of missing values for the main exposures was conducted: missing BW values were replaced with the minimum (1.26 kg) and the maximum (5.50 kg) non-missing value of BW recorded, and final models re-run for both scenarios. Similarly, missing values for WAZ change were replaced with the smallest and largest change in WAZ for the given growth period.

• lule, swaib a.
• namara, benigna
• akurut, hellen
• muhangi, lawrence
• lubyayi, lawrence
• nampijja, margaret
• akello, florence
• tumusiime, josephine
• aujo, judith c.
• oduru, gloria
• smeeth, liam
• elliott, alison m.
• webb, emily l.